Joachim Gullbo

Joachim Gullbo has extensive experience in the field of oncology. Joachim currently works as a Medical Monitor at Theradex Oncology, a position they have held since 2017. Prior to this, they held the role of Adjunct professor at Uppsala University from 2009 to 2022. Joachim also worked as a Scientific Advisor at Oncopeptides AB from 2011 to 2022 and as a Scientist from 2001 to 2012. In addition, Joachim served as the Head of Oncology at Akademiska sjukhuset from 2015 to 2017 and as a Consultant in Oncology at Uppsala Academic Hospital from 2005 to 2017. Earlier in their career, they were the Chief Medical Officer at Vivolux Inc from 2012 to 2015. Joachim's work also includes research and a role as a PHD Student in Clinical Pharmacology at Uppsala University from 1997 to 2003.

Joachim Gullbo received their MSc Pharmacy from Uppsala University in 1996. Joachim then went on to earn a Doctor of Medicine (MD) degree from the same institution in 2002. In 2003, they completed their Doctor of Philosophy (PhD) degree in Clinical Pharmacology, also from Uppsala University. Joachim Gullbo later became an Associate Professor in Experimental Clinical Pharmacology at Uppsala University, a position they held until 2010.